403 related articles for article (PubMed ID: 19696787)
1. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
[TBL] [Abstract][Full Text] [Related]
2. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts.
Maes OC; Sarojini H; Wang E
J Cell Physiol; 2009 Oct; 221(1):109-19. PubMed ID: 19475566
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
4. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
Tazawa H; Tsuchiya N; Izumiya M; Nakagama H
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15472-7. PubMed ID: 17875987
[TBL] [Abstract][Full Text] [Related]
7. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
9. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C
Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834
[TBL] [Abstract][Full Text] [Related]
10. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
12. Immortalized mouse embryo fibroblasts are resistant to miR-290-induced senescence regardless of p53 status.
Rizzo M; Evangelista M; Mariani L; Simili M; Rainaldi G; Pitto L
Physiol Genomics; 2011 Oct; 43(20):1153-9. PubMed ID: 21846807
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
14. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
Chen F; Hu SJ
J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
[TBL] [Abstract][Full Text] [Related]
15. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
Chen X; Yan J; Chen T
Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
[TBL] [Abstract][Full Text] [Related]
16. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
[TBL] [Abstract][Full Text] [Related]
17. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
18. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.
Rippo MR; Olivieri F; Monsurrò V; Prattichizzo F; Albertini MC; Procopio AD
Exp Gerontol; 2014 Aug; 56():154-63. PubMed ID: 24607549
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
[TBL] [Abstract][Full Text] [Related]
20. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]